SIM
VNRX icon

Spark Investment Management’s VolitionRx Ltd VNRX Stock Holding History

Spark Investment Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-880
Closed -$72K – 738
2015
Q1 		$72K Buy
+880
New +$72.9K 0.01% 649

Other funds holding VNRX

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Spark Investment Management's VNRX Position: Q2 2015 in Review

Spark Investment Management sold out of VolitionRx Ltd (VNRX) in Q2 2015, closing a stake of 880 shares — an estimated $72K sold.

Spark Investment Management first reported a position in VNRX in Q1 2015 and held it in 1 quarter. The position peaked at $72K in Q1 2015. 7 funds tracked by Wall St. Rank hold VNRX as of Q2 2015.

  • Spark Investment Management reported no remaining VolitionRx Ltd position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 880 VolitionRx Ltd shares in Q2 2015, an estimated $72K.
  • Spark Investment Management first reported a position in VolitionRx Ltd in Q1 2015 and held it in 1 quarter.
  • Spark Investment Management's VolitionRx Ltd position peaked at $72K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.